Mani Srinivasan MD is categorized under Mail Order Pharmaceuticals in New Hartford, NY and active since 1988.
Mani Srinivasan MD was established in 1988, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Mail Order Pharmaceuticals business, which does work in the B2C market, and is classified as a Mail Order Pharmaceuticals, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Srinivasan Mani at the company’s single location by writing to 1729 Burrstone Road, New Hartford, New York NY 13413 or by phoning (315) 798-1659. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mani Srinivasan MD |
| Contact Person: | Srinivasan Mani |
| Address: | 1729 Burrstone Road, New Hartford, New York 13413 |
| Phone Number: | (315) 798-1659 |
| Website Address: | sdmg.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1988 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Mail Order Pharmaceuticals |
| SIC Code: | 5961 |
| NAICS Code: | 6211110 |
| Share This Business: |
Mani Srinivasan MD was started in 1988 to provide professional Mail Order Pharmaceuticals under the SIC code 5961 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Srinivasan Mani for inquiries that concern Mani Srinivasan MD by calling the company number (315) 798-1659, as your correspondence is most welcome. Additionally, the physical location of the single location of Mani Srinivasan MD can be found at the coordinates 43.094445,-75.281084 as well as the street address 1729 Burrstone Road in New Hartford, New York 13413.
For its online presence, you may visit Mani Srinivasan MD’s website at sdmg.com and engage with its social media outlets through on Twitter and on Facebook.